DBV Technologies (DBVT) Change in Cash (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Change in Cash of -$54.2 million for Q2 2026, down 160.02% year-on-year from $90.3 million in Q2 2025, and down 254.86% on a QoQ basis from $35.0 million in Q1 2026.
DBV Technologies (DBVT) Change in Cash (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Change in Cash for 7 consecutive years, with -$54.2 million the latest figure, recorded in Q2 2026.
- Quarterly Change in Cash fell 160.02% year-over-year to -$54.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $71.7 million (up 93.6% YoY) and the FY2025 annual result came in at $161.7 million, up 248.48% from the prior year.
- Change in Cash retreated to -$54.2 million in Q2 2026 per DBVT's latest filing, from $35.0 million in the prior quarter.
- Over the last five years, Change in Cash for DBVT reached as high as $173.9 million in Q2 2022 and fell as low as -$54.2 million in Q2 2026.
- A 5-year average of $5.4 million and a median of -$17.6 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 429.27% — and 2025, when it soared 988.83%.
- Year by year, Change in Cash stood at -$3.5 million in 2022, then sank by 123.48% to -$7.8 million in 2023, then tumbled by 80.07% to -$14.0 million in 2024, then surged by 988.83% to $124.3 million in 2025, then sank by 143.59% to -$54.2 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$54.2 million, $35.0 million, and $124.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -54.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.20 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 124.33 Mn |
| Sep 30, 2025 | -33.42 Mn |
| Jun 30, 2025 | 90.30 Mn |
| Mar 31, 2025 | -19.50 Mn |
| Dec 31, 2024 | -13.99 Mn |
| Sep 30, 2024 | -19.77 Mn |
| Jun 30, 2024 | -35.31 Mn |
| Mar 31, 2024 | -39.84 Mn |
| Dec 31, 2023 | -7.77 Mn |
| Sep 30, 2023 | -24.83 Mn |
| Jun 30, 2023 | -18.33 Mn |
| Mar 31, 2023 | -16.91 Mn |
| Dec 31, 2022 | -3.48 Mn |
| Sep 30, 2022 | -35.30 Mn |
| Jun 30, 2022 | 173.86 Mn |
| Mar 31, 2022 | -3.19 Mn |
| Dec 31, 2021 | -20.89 Mn |
| Sep 30, 2021 | -27.29 Mn |